Clinical Trials on Allergy in United States

Total 777 results

Brian J Lipworth

Withdrawn

Preventing Tolerance to Oxymetazoline in Allergic Rhinitis

Allergic Rhinitis | Tachyphylaxis | Rhinitis Medicamentosa

United Kingdom
Bayer

Terminated

Exploratory Study for Allergy Relief Onset

Rhinitis, Allergic

United States
National Institute of Allergy and Infectious Diseases...

Terminated

A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitis

Eczema | Atopic Dermatitis | Allergic Disease | Anakinra | Kineret

United States
Bernstein, Jonathan A., M.D.
Merck Sharp & Dohme LLC

Unknown

Singulair Use in Non-Allergic Rhinitis Eosinophil Syndrome (NARES)

Rhinitis

United States
University of Aberdeen
Merck Sharp & Dohme LLC

Unknown

Montelukast and Nasal Epithelial Cell Inflammatory Responses in Asthma and Rhinitis

Asthma | Allergic Rhinitis

United Kingdom
Greer Laboratories

Completed

Efficacy Study of Sublingual Immunotherapy to Treat Ragweed Allergies

Allergic Rhinitis

United States
AstraZeneca

Completed

To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402)

Rhinitis, Allergic, Perennial

United States
Duke University
Regeneron Pharmaceuticals

Recruiting

IL13 Signaling in Allergic Asthma

Obesity | Asthma | Asthma, Allergic

United States
University of Dundee

Completed

Steroid Sparing Effect of Nasal Corticosteroid In Asthma And Rhinitis

Asthma | Allergic Rhinitis

United Kingdom
Brian J Lipworth

Completed

Differential Adrenoreceptor Mediated Tachyphylaxis and Upregulation

Allergic Rhinitis | Tachyphylaxis | Rhinitis Medicamentosa

United Kingdom
Zambon SpA

Completed

Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic Subjects

Allergic Bronchopulmonary Aspergillosis

United Kingdom
HealthMode Inc.

Completed

Audio Data Collection for Identification and Classification of Coughing

Coronavirus Infections | Respiratory Tract Infections | COVID-19 | Healthy | Chronic Obstructive Pulmonary Disease | Asthma | Influenza | Common Cold | Hay Fever

United States
Dynavax Technologies Corporation

Terminated

Efficacy and Safety Study of TOLAMBA™ in Ragweed-Allergic Adults

Rhinitis, Allergic, Seasonal

United States
Nabeel Hamzeh
National Jewish Health

Completed

Immune Response in Hypersensitivity Pneumonitis

Hypersensitivity Pneumonitis

United States
University of South Florida

Terminated

Oxymetazoline Hydrochloride in Combination With Nasal Glucocorticosteroid for Perennial Allergic and Non-allergic Rhinitis in Subjects With Persistent Nasal Congestion

Chronic Rhinitis

United States
GlaxoSmithKline

Completed

A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics

Rhinitis, Allergic, Perennial

United States
University of Washington
Agency for Healthcare Research and Quality (AHRQ)

Completed

A Trial of Point of Care Information in Ambulatory Pediatrics

Constipation | Sinusitis | Allergic Rhinitis | Bronchiolitis | Urticaria | Pharyngitis | Croup | Acute Otitis Media

United States
GlaxoSmithKline

Completed

A Clinical Study With Fluticasone Furoate Nasal Spray And Vehicle Placebo For The Treatment Of Perennial (Year-round) Allergic Rhinitis

Rhinitis, Allergic, Perennial

United States
Genentech, Inc.

Completed

A Study Evaluating the Persistency of Response With or Without Xolair (Omalizumab) After Long-term Therapy (XPORT)

Allergic Asthma

United States
Meda Pharmaceuticals

Completed

3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis

Allergic Rhinitis

United States
GlaxoSmithKline

Completed

Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS

Rhinitis, Allergic, Perennial

United States
GlaxoSmithKline

Completed

Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS

Rhinitis, Allergic, Perennial

United States
Magna Pharmaceuticals, Inc.

Unknown

StahistRx Phase 2, Five-arm, Parallel Group, Active vs Active, Double-blind Study

Rhinitis, Seasonal, Allergic

United States
AstraZeneca

Completed

Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR) (BY9010/M1-602)

Rhinitis, Allergic, Seasonal

United States
Pulmatrix Inc.

Terminated

Study in Adult Asthmatic Patients With Allergic Bronchopulmonary Aspergillosis

Allergic Bronchopulmonary Aspergillosis

United States, Australia, United Kingdom, India, Poland
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Study in Adult and Adolescent Subjects With PAR (Perennial Allergic Rhinitis)

Rhinitis, Allergic, Perennial

United States
The University of Texas Health Science Center,...
American Academy of Otolaryngic Allergy & Foundation

Recruiting

The Prevalence of Local Immunoglobulin E (IgE) Elevation and Its Effect on Intranasal Capsaicin Therapy in the Non-allergic Rhinitis Population

Non-allergic Rhinitis

United States
Evans Fernandez Perez
Genentech, Inc.

Terminated

Study of Efficacy and Safety of Pirfenidone in Patients With Fibrotic Hypersensitivity Pneumonitis

Interstitial Lung Disease

United States
University of Texas Southwestern Medical Center
AstraZeneca

Completed

Efficacy of Esomeprazole for Non-Allergic Rhinitis: A Double-blind, Placebo Controlled Trial

Vasomotor Rhinitis

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)

Allergic Rhinitis

United States
GlaxoSmithKline

Completed

Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine

Rhinitis, Allergic, Seasonal

United States
AstraZeneca

Completed

Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490)

Rhinitis, Allergic, Perennial

United States
Community Pharmacology Services Ltd
Pulmatrix Inc.

Withdrawn

Allergic Bronchopulmonary Aspergillosis Prescreening Study

Asthma | Allergic Bronchopulmonary Aspergillosis | ABPA

United Kingdom
GlaxoSmithKline

Completed

Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)

Rhinitis, Allergic, Perennial

Australia, Estonia, United States, Germany, Canada, New Zealand, Russian Federation, Lithuania, Latvia
GlaxoSmithKline

Completed

A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis

Rhinitis, Allergic, Perennial

Estonia, United States, Canada, Germany, Slovakia, Russian Federation, Hungary
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 mcg in Allergic Rhinitis

Rhinitis, Allergic, Perennial

United States
Columbia University

Recruiting

Allergy and Immunology Natural History Study

Immune Deficiency | Allergic Inflammation | Immune Dysregulation Disorder

United States
GlaxoSmithKline

Completed

Phase 4 Fluticasone Furoate Nasal Spray (VERAMYST) Long Term Pediatric Growth Study.

Rhinitis, Allergic, Perennial

United States, Argentina, Canada, France, Peru, Italy, Chile
Genentech, Inc.

Terminated

A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma (EDURO)

Moderate-to-severe Allergic Asthma

United States
GlaxoSmithKline

Completed

Perennial Allergic Rhinitis Study In Pediatric Subjects

Rhinitis, Allergic, Perennial

United States, Argentina, Slovakia, Finland, Chile, Mexico, Italy
GlaxoSmithKline

Completed

A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).

Rhinitis, Allergic, Perennial

United States, Canada
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study to Describe the Allergic Reactions to Factor IX in Patients With Hemophilia B

Hemophilia B | Allergic Reactions

France, Italy, United States, Austria, Belgium, Spain, United Kingdom, Canada, Germany
Regeneron Pharmaceuticals
Sanofi

Completed

Investigating Treatment With Dupilumab in Patients With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED)

Allergic Bronchopulmonary Aspergillosis

United States, Hungary, Bulgaria, France, Germany, Japan, Netherlands, Poland, Romania, United Kingdom
National Institute of Allergy and Infectious Diseases...
Immune Tolerance Network (ITN)

Completed

Promoting Tolerance to Common Allergens in High-Risk Children: Global Prevention of Asthma in Children (GPAC) Study (GPAC)

Asthma | Allergic Sensitization

United States, Australia
University of Wisconsin, Madison
University of Chicago; National Institutes of Health (NIH); University of California... and other collaborators

Completed

Children's Respiratory and Environmental Workgroup (CREW02)

Healthy | Asthma | Allergic Asthma | Allergies

United States
UCB Pharma

Completed

Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months (BALL)

Allergic Rhinitis | Chronic Urticaria

United States
Imperial College London

Completed

Development of Human Nasal Challenge Models With Microbial Constituents and Grass Pollen

Asthma | Latent Tuberculosis | Allergic Rhinitis

United Kingdom
Aerovance, Inc.

Completed

Effects of AER 001 Administered by Nebulization on Antigen Challenge in Atopic Asthmatics

Allergic Asthma

United Kingdom
Sanofi
Regeneron Pharmaceuticals

Active, not recruiting

Dupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI)

Allergic Fungal Rhinosinusitis

China, Argentina, Israel, United States, Canada, India, Japan, Saudi Arabia, Turkey
Novartis Pharmaceuticals
Genentech, Inc.

Completed

Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists (eXplore)

Allergic Asthma

United States, Sweden, United Kingdom, France, Canada, Germany, Netherlands

Clinical Trials on Allergy in United States

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations